PRAXIS Trademark

Trademark Overview

On Thursday, January 13, 2022, a trademark application was filed for PRAXIS with the United States Patent and Trademark Office. The USPTO has given the PRAXIS trademark a serial number of 97217426. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, October 15, 2024. This trademark is owned by Praxis Precision Medicines, Inc.. The PRAXIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological disorders and central nervous system disorders
praxis

General Information

Serial Number97217426
Word MarkPRAXIS
Filing DateThursday, January 13, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 23, 2022

Trademark Statements

Description of MarkThe mark consists of the word "PRAXIS" with a stylized letter "X" formed by uneven checkmarks.
Goods and ServicesPharmaceutical preparations for the treatment of neurological disorders and central nervous system disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePraxis Precision Medicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02110
Party NamePraxis Precision Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02110

Trademark Events

Event DateEvent Description
Monday, April 4, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 17, 2022NEW APPLICATION ENTERED
Thursday, January 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 4, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 4, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 13, 2022ASSIGNED TO EXAMINER
Saturday, July 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 3, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 23, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 23, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 18, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 13, 2023SOU EXTENSION 1 FILED
Thursday, April 13, 2023SOU EXTENSION 1 GRANTED
Tuesday, October 10, 2023SOU TEAS EXTENSION RECEIVED
Saturday, April 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 10, 2023SOU EXTENSION 2 FILED
Tuesday, October 10, 2023SOU EXTENSION 2 GRANTED
Thursday, October 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 16, 2024SOU EXTENSION 3 FILED
Tuesday, April 16, 2024SOU EXTENSION 3 GRANTED
Wednesday, April 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 15, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 15, 2024SOU EXTENSION 4 FILED
Tuesday, October 15, 2024SOU EXTENSION 4 GRANTED
Monday, October 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 18, 2025SOU TEAS EXTENSION RECEIVED

Related Keywords

praxis disorders central system nervous neurological preparations treatment pharmaceutical